If you’ve been following along in our Boswellia series, you already know why we’ve been talking about this plant so much.
Research shows Boswellia serrata can help:
Those are the areas with the strongest and most consistent evidence, and we’ve explored each of them in detail.
But that’s not the whole story.
As research has expanded, scientists have started looking at Boswellia’s effects beyond these core uses. What they’re finding is a botanical that may influence a wider range of inflammatory and immune-related conditions—from digestive disorders and respiratory inflammation to early research in neurological health and supportive care settings.
None of this makes Boswellia a cure-all. And much of this research is still early.
But it does suggest something important: Boswellia’s effects aren’t limited to one system; they reflect its broader role in helping regulate inflammation throughout the body.
Let’s take a look at what the emerging research is exploring.
Boswellia and Inflammatory Bowel Disease (IBD)
This is, in a way, an extension of our deep dive into the gut-brain connection blog.
We know that IBD is driven by chronic intestinal inflammation, making it a logical area of interest for compounds known to influence inflammatory signaling, especially leukotrienes, which play a role in gut immune responses.
Several notable human studies have explored this connection:
-
In one clinical trial involving people with ulcerative colitis, participants who took a Boswellia resin preparation for six weeks achieved remission rates of about 75%, similar to those seen with the prescription drug sulfasalazine.
-
Another randomized study in people with active Crohn’s disease found that a standardized Boswellia extract performed comparably to mesalazine, a commonly used anti-inflammatory medication, and was well tolerated.
Asthma and Respiratory Inflammation
Another area where Boswellia continues to attract interest is asthma and allergic respiratory inflammation.
Asthma is not just airway constriction; it’s a chronic inflammatory condition. One of the key drivers is a group of inflammatory molecules called leukotrienes, which contribute to airway swelling, mucus production, and immune cell recruitment.
Because boswellic acids inhibit the enzyme responsible for leukotriene production, researchers have explored their role in allergic inflammation. Preclinical studies show Boswellia compounds can reduce airway inflammation and modulate immune responses associated with asthma.
Animal studies consistently report reduced airway inflammation and improved respiratory markers. At this point, human evidence is limited, but small clinical trials have reported improvements in asthma symptoms and lung function. Larger studies are still needed to confirm these findings.
Cancer Research: What’s Being Studied?
Cancer research is where conversations around supplements can go off the rails quickly, so we have to be very clear. Boswellia extract is not a cancer treatment, and no credible research suggests it should be used as one.
That said, researchers have studied Boswellia compounds in laboratory and animal models to better understand how they interact with cancer-related processes.
In these early studies, boswellic acids have shown the ability to:
-
Encourage apoptosis (programmed cell death) in cancer cells
-
Slow cancer cell growth and division
-
Interfere with angiogenesis (the formation of new blood vessels that tumors rely on)
-
Affect pathways involved in tumor spread
These findings have been observed across several cancer cell lines, including breast, colon, prostate, pancreatic, and brain cancers. Some studies also suggest that boswellic acids may act more selectively on cancer cells than on healthy cells.
However, it’s important to understand what this means.
Most of this research comes from cell cultures or animal models, which do not reflect the complexity of cancer treatment in humans.
Human evidence is very limited.
The most relevant study looked at people with brain tumors undergoing radiation therapy. In that small trial, Boswellia extract helped reduce cerebral edema (brain swelling), which improved quality-of-life symptoms such as headaches and neurological discomfort.
However, the extract did not reduce tumor size or slow disease progression.
This means, Boswellia’s potential role—if any—is as a supportive therapy under medical supervision, not as a treatment or alternative to standard cancer care.
Emerging Neurological and Neuroinflammatory Research
A lesser-known but intriguing area of research involves Boswellia’s interaction with the nervous system.
Some boswellic acids are able to cross the blood–brain barrier, which has prompted studies into their effects on neuroinflammation. Early findings include:
-
Reduced brain inflammation and oxidative stress in animal models
-
Data suggesting benefit in post-stroke recovery
-
Reduced brain edemas in specific clinical contexts
These findings are still early and limited, but they align with a broader pattern seen throughout Boswellia research.
Bringing Boswellia into a Thoughtful Wellness Routine
If there’s one thing the research makes clear, it’s this: Boswellia’s effects are more complex and aren’t limited to one condition or one part of the body. Whether the focus is joint comfort, gut health, respiratory inflammation, or other emerging areas, the common thread is its ability to help manage underlying inflammatory signals that affect multiple systems at once.
And because inflammation tends to build gradually over time, support usually works best when it’s consistent and gentle, rather than aggressive or short-term.
If you’re looking for products infused with Boswellia Serrata Extract to manage pain or inflammation, try our Relief F1 topical salve. It delivers Boswellia directly where it’s needed, along with complementary ingredients chosen to support the body’s natural response to inflammation. We offer free shipping in the United States.